BCYC
Price
$14.11
Change
+$0.24 (+1.73%)
Updated
Nov 29, 2:20 PM EST
90 days until earnings call
PHIO
Price
$0.98
Change
+$0.11 (+12.64%)
Updated
Nov 29, 3:38 PM EST
Ad is loading...

Compare trend and price BCYC vs PHIO

Header iconBCYC vs PHIO Comparison
Open Charts BCYC vs PHIOBanner chart's image
Bicycle Therapeutics
Price$14.11
Change+$0.24 (+1.73%)
Volume$304
CapitalizationN/A
Phio Pharmaceuticals
Price$0.98
Change+$0.11 (+12.64%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
BCYC vs PHIO Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
BCYC vs. PHIO commentary
Nov 29, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Buy and PHIO is a Hold.

COMPARISON
Comparison
Nov 29, 2023
Stock price -- (BCYC: $13.87 vs. PHIO: $0.94)
Brand notoriety: BCYC and PHIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 34% vs. PHIO: 2%
Market capitalization -- BCYC: $525M vs. PHIO: $2.32M
BCYC [@Biotechnology] is valued at $525M. PHIO’s [@Biotechnology] market capitalization is $2.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whilePHIO’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • PHIO’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than PHIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 6 TA indicator(s) are bullish while PHIO’s TA Score has 5 bullish TA indicator(s).

  • BCYC’s TA Score: 6 bullish, 2 bearish.
  • PHIO’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than PHIO.

Price Growth

BCYC (@Biotechnology) experienced а +3.05% price change this week, while PHIO (@Biotechnology) price change was -3.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.02%. For the same industry, the average monthly price growth was +37.81%, and the average quarterly price growth was +8.99%.

Reported Earning Dates

BCYC is expected to report earnings on Feb 27, 2024.

PHIO is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (+5.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
A.I.dvisor published
a Summary for PHIO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BCYC($525M) has a higher market cap than PHIO($2.32M). BCYC YTD gains are higher at: -53.142 vs. PHIO (-78.943). PHIO has higher annual earnings (EBITDA): -11.47M vs. BCYC (-151.28M). BCYC has more cash in the bank: 572M vs. PHIO (8.41M). PHIO has less debt than BCYC: PHIO (70K) vs BCYC (45.7M). BCYC has higher revenues than PHIO: BCYC (24.8M) vs PHIO (0).
BCYCPHIOBCYC / PHIO
Capitalization525M2.32M22,639%
EBITDA-151.28M-11.47M1,319%
Gain YTD-53.142-78.94367%
P/E RatioN/AN/A-
Revenue24.8M0-
Total Cash572M8.41M6,804%
Total Debt45.7M70K65,286%
FUNDAMENTALS RATINGS
PHIO: Fundamental Ratings
PHIO
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCPHIO
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRT94.040.34
+0.36%
Federal Realty Investment Trust
CVRX19.90-0.25
-1.24%
CVRx
GECC9.92-0.26
-2.55%
Great Elm Capital Corp
DVAX13.28-0.35
-2.57%
Dynavax Technologies Corp
SVRE0.40-0.02
-5.48%
SaverOne 2014 Ltd

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with DYN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-0.36%
DYN - BCYC
42%
Loosely correlated
-2.44%
PHIO - BCYC
41%
Loosely correlated
-0.95%
MLTX - BCYC
39%
Loosely correlated
-3.82%
DNLI - BCYC
35%
Loosely correlated
+2.12%
SWTX - BCYC
35%
Loosely correlated
+18.68%
More

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been loosely correlated with TPST. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PHIO jumps, then TPST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
-0.95%
TPST - PHIO
57%
Loosely correlated
-0.80%
MTNB - PHIO
53%
Loosely correlated
+0.20%
IMNN - PHIO
39%
Loosely correlated
-0.11%
BCYC - PHIO
33%
Loosely correlated
-0.36%
NTBL - PHIO
30%
Poorly correlated
-1.25%
More